SMi proudly presents the return of the 19th annual Superbugs & Superdrugs conference to London in 2017!
Each year, around 2 million people are taken ill in the US from antibiotic-resistant bacteria and kill at least 23,000, according to estimates by the Centers for Disease Control and Prevention. The threat is so high that in September 2014 President Barack Obama issued an executive order Combating Antibiotic-Resistant Bacteria. *
The threat is the same in Europe, big pharmaceutical companies are re-entering the space into the development of new antibiotics after decades. In January 2016, more than 80 pharmaceutical, biotechnology and diagnostics companies including Roche, Pfizer, Novartis AG and GlaxoSmithKline pledged at the World Economic Forum to fight the threat of antimicrobial resistance.*
SMi’s 19th annual Superbugs & Superdrugs conference will explore the magnitude of this threat and the solutions to the problem. The 2-day conference will present exclusive case studies from a mix of big pharma and biotech on their current strategies to combat Antibiotic-Resistant Bacteria. The conference will provide the platform to exchange novel solutions and consolidate current strategies with the leaders of the superbug & Superdrug community.
This content is blocked. Accept cookies to view the content.